Conditions: Rhinitis, Allergic, Perennial
Keywords: allergic rhinitis fluticasone furoate nasal spray growth
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 474
Healthy volunteers: no

Brief summary:
The primary objective of this study is to characterize, as accurately as possible, the estimation of the difference in pre-pubescent growth velocities between subjects treated continuously for one year with FFNS 110mcg QD, the highest dose approved for pediatric use in the US, and placebo nasal spray as determined by stadiometry.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Fluticasone furoate nasal spray intervention 2: Placebo nasal spray
Intervention descriptions: intervention 1: Fluticasone furoate nasal spray 110mg QD intervention 2: Placebo nasal spray

Protocol document: